Contact

 

Prof. Dr. Dr. Jürgen Debus 
Phone: +49 6221 568200

E-mail: Juergen.Debus@med.uni-heidelberg.de

 

 

It is crucial...

 

to hit the target.

Department of Radiation Oncology

 

2010 – 2013

  • Schmidt J, Abel U, Debus J, Harig S, Hoffmann K, Herrmann T, Bartsch D, Klein J, Mansmann U, Jäger D, Capussotti L, Kunz R, Büchler MW. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma. J Clin Oncol. 2012 Nov 20;30(33):4077-83.

  • Rieken S, Habermehl D, Nikoghosyan A, Jensen A, Haberer T, Jäkel O, Münter MW, Welzel T, Debus J, Combs SE. Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e793-801. doi: 10.1016/j.ijrobp.2010.12.018. Epub 2011 Feb 6. PubMed PMID: 21300464.

  • Askoxylakis V, Garcia-Boy R, Rana S, Krämer S, Hebling U, Mier W, Altmann A, Markert A, Debus J, Haberkorn U. A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology. PLoS One. 2010 Dec 31;5(12):e15962. doi: 10.1371/journal.pone.0015962. PubMed PMID: 21209841; PubMed Central PMCID: PMC3013143.

  • Sterzing F, Hauswald H, Uhl M, Herm H, Wiener A, Herfarth K, Debus J, Krempien R. Spinal cord sparing reirradiation with helical tomotherapy. Cancer. 2010 Aug 15;116(16):3961-8. doi: 10.1002/cncr.25187. PubMed PMID: 20564110.

  • Erkan M, Weis N, Pan Z, Schwager C, Samkharadze T, Jiang X, Wirkner U, Giese NA, Ansorge W, Debus J, Huber PE, Friess H, Abdollahi A, Kleeff J. Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer. 2010 Apr 23;9:88. doi: 10.1186/1476-4598-9-88. PubMed PMID: 20416094; PubMed Central PMCID: PMC2876060.